Min Bao, M.D., M.Sc.

Min Bao, M.D., M.Sc.

Senior Vice President, Clinical Development

Min is responsible for the Clinical Development, Clinical Pharmacology & Toxicology and Safety/Pharmacovigilance at Anaptys. Previously, Min was senior vice president of Clinical Development at Alpine Immune Sciences (acquired by Vertex Pharmaceuticals). Prior to Alpine, she was the head of Autoimmune Franchise at Annexon Biosciences and Global Development Lead at Genentech/Roche. During her 22-year tenure at Genentech/Roche, she developed diversified drug development skills across multiple therapeutic areas. She contributed and led development activities from pre-IND to global approvals in autoimmune indications and severe COVID-19. Min received her M.D. from the Medical College of Suzhou University in China, and a Master of Science in Immunology from the University of Calgary.